12.02.2013 Views

New Modes of GPCR Signalling

New Modes of GPCR Signalling

New Modes of GPCR Signalling

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TEF3(Transcription Enhancer Factor 3)Induced Angiogenesis through<br />

VEGF Pathway<br />

Xin Liu1, Cheng Qiao1, and Dezheng Zhao2,4 Huiyan Zeng2,3,4*,<br />

1.Department <strong>of</strong> Microbiological and Biochemical Pharmacy, College <strong>of</strong> Pharmacy ,<br />

Wuhan University, Wuhan 430071, PR China 2 .Departments <strong>of</strong> Pathologyand<br />

Medicine (Division <strong>of</strong> Molecular & Vascular Medicine), 3. Center for vascular Biology<br />

Research 4.Beth Israel Deaconess Medical Center and Harvard Medical School, Boston<br />

MA 02215, USA<br />

Aims: Transcription Enhancer Factor-3 (TEF3, RTEF-1, TEAD4) belongs to a family<br />

<strong>of</strong> transcription factor proteins. Although it has been extensively studied, the signaling<br />

pathways mediating its biological functions during angiogenensis are still not<br />

understood. Recently we identified a novel VEGF targeted gene, Down Syndrome<br />

Candidate Region 1 is<strong>of</strong>orm 1L (DSCR1-1L) that is important for the function <strong>of</strong> VEGF<br />

in pathological angiogenesis and is expressed in human tumor vasculature, not in<br />

normal vasculature, rendering it a specific target for tumor angiogenesis therapy. TEF3<br />

was required for DSCR1-1L expression through binding to the M-CAT site in its<br />

promoter and could be an attractive target for anti-angiogenesis therapy. It was also<br />

reported that TEF3 expression is induced by hypoxia and TEF3 overexpression<br />

increases VEGF gene transcription and in vitro under hypothexia condition. Ours aims<br />

are to investigate the role <strong>of</strong> TEF3 in angiogenesis. Methods: We overexpressed TEF3<br />

in HUVEC cell and we used the yeast two-hybrid system to find the proteins interaction<br />

with the TEF3. Results: We reported previously that another DSCR1 is<strong>of</strong>orm,<br />

DSCR1-1L, was also upregulated by VEGF-A 165 in cultured endothelial cells and in<br />

several in vivo models <strong>of</strong> pathological angiogenesis and that different from DSCR1-4,<br />

DSCR1-1L overexpression alone induced cultured endothelial cell proliferation and<br />

promoted angiogenesis in Matrigel assays. We also demonstrated that TEF3 directly<br />

interacted with the putative M-CAT site in the DSR1-1L promoter in vitro and in vivo.<br />

Finally, Overexpression <strong>of</strong> TEF3 induces HUVEC proliferation, migration and tube<br />

formation. Conclusion: TEF3 upregulatecd DSCR1-1l expression with the VEGF<br />

stimulation,and TEF3 itself can promote angiogenesis in endothelial cells. Then it was<br />

tested that TEF3 also acts as a novel factor in VEGF-induced angiogenesis signaling<br />

pathway.<br />

Key Words: VEGF; TEF3; angiogenesis<br />

Authors:<br />

Xin Liu ,Email: lx@whu.edu.cn;<br />

Huiyan Zeng, Email: hzeng@caregroup.harvard.edu Tel: 86-27-68759006

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!